"Located just minutes from the Gold Coast’s world-famous beaches, the campus offers a dynamic and exciting student lifestyle, with extensive sporting amenities, handy on-campus services and a range of cafes and restaurants. The campus has seen significant growth and development with the opening of the $150 million Griffith Health Centre in 2013 and the launch of the $38 million Griffith Business School building in 2014."

During the past decade, Griffith University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Griffith University" #1 sponsor was "AstraZeneca" with 1 trials, followed by "Becton, Dickinson and Company" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored and "Paradigm Biopharmaceuticals USA (INC)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Griffith University" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Griffith University" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Griffith University" are "Alzheimer´s Disease" (1 trials), "Indication for Peripheral Intravenous Catheterisation" (1 trials), "Osteoarthritis, Knee" (1 trials), "Respiratory Syncytial Virus" (1 trials) and "Seasonal Influenza" (1 trials). Many other conditions were trialed in "Griffith University" in a lesser frequency.

Most popular intervention types in "Griffith University" are "Drug" (3 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (1 trials), "Lanabecestat" (1 trials), "Licensed quadrivalent inactivated seasonal influenza vaccine" (1 trials) and "Pentosan Polysulfate Sodium Fixed Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Griffith University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Griffith University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Griffith University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Griffith University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".